China's original technology provides a new solution for the treatment of hypertrophic cardiomyopathy worldwide
2026-11-17 20:50:28
According to CoinMeta, on November 17th Beijing time, the international leading journal in the field of cardiovascular medicine, "Circulation," published two articles introducing the latest achievements of Professor Wei Xiang's team from the Department of Cardiac Surgery at Tongji Hospital, affiliated with Tongji Medical College of Huazhong University of Science and Technology, in the treatment of hypertrophic cardiomyopathy. The team pioneered a minimally invasive procedure known as apical non-stop beating ventricular septal myectomy ( TA-BSM ). This surgical technique effectively covers the treatment of both obstructive and non-obstructive hypertrophic cardiomyopathy, breaking through the limitations of traditional treatments and providing a Chinese-based solution for the global management of this condition.
Source:Jin10 Data
This content is for market information only and does not constitute investment advice.
Follow CoinMeta official accounts to stay updated

Hot Articles
Refresh

What Is Bitmine? Why the Largest ETH Treasury Halted Buys
17h ago

NVIDIA's stock tumbles 9% after the latest announcement; what impact will NVIDIA's decline have on the AI industry?
11-12 16:08

Is the Tangem wallet secure? No need to memorize a mnemonic phrase, can beginners use it with confidence?
11-12 17:31

SOL Currency's Latest Price Outlook: Can It Break Through the $90 Barrier?
11-11 11:59

Dow Jones 1,000-Point Swings: CPI Reversal or Bull Trap?
11-10 16:56



